Cardinal Health, Inc. (NYSE:CAH) continues to impress investors and financial analysts with its impressive performance and strategic business decisions. Enjoying a massive
88% institutional ownership, as well as fresh dividends being announced for this spring, the company’s stock rating has been increased to a 'Buy' by both Jefferies Financial Group and JPMorgan Chase & Co. It also announced its plan to continuously reward share-holders with another
$0.51 dividend offering. This positive news is followed by the announcement of two strategic additions to its portfolio, adding substantially to the company's strength and stability. Other important announcements include Cardinal Health's plan to open a
new distribution center in Fort Worth, Texas and its successful earning expectations beat in Q4. The company's consistent satisfactory performance has analysts predicting an
increase in the stock's future prices, creating a positive outlook for both short-term and long-term investors. Furthermore,
Cardinal Health has also announced the future acquisition of the
Integrated Oncology Network, marking a very strategic move in expanding its service offerings. Lastly, a noteworthy mention is the unusually large options volume being observed.
Cardinal Health CAH News Analytics from Wed, 14 Aug 2024 07:00:00 GMT to Sat, 08 Feb 2025 12:00:19 GMT -
Rating 8
- Innovation 4
- Information 6
- Rumor -4
